Lani Ibarra
Technik-/Wissenschafts-/F&E-Leiter bei STRUCTURE THERAPEUTICS INC.
Profil
Lani Ibarra is currently working as the Senior VP-Clinical Development Operations at Structure Therapeutics, Inc. Previously, Lani held positions as the Vice President-Clinical Operations at Dynavax Technologies Corp., Vice President-Global Clinical Operations at Molecular Partners AG, and Vice President-Global Clinical Operations at Molecular Partners,.
Inc. Lani obtained a graduate degree from Stanford University and an undergraduate degree from the University of California, Berkeley.
Aktive Positionen von Lani Ibarra
| Unternehmen | Position | Beginn |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Lani Ibarra
| Unternehmen | Position | Ende |
|---|---|---|
| MOLECULAR PARTNERS AG | Technik-/Wissenschafts-/F&E-Leiter | - |
Molecular Partners, Inc.
 Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Corporate Officer/Principal | - |
| DYNAVAX TECHNOLOGIES CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Lani Ibarra
| Stanford University | Graduate Degree |
| University of California, Berkeley | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
| STRUCTURE THERAPEUTICS INC. | Commercial Services |
| MOLECULAR PARTNERS AG | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Health Technology |
